Evidence map›Paper›PMID 29855728›Full record

ArticleEJNMMI research2018

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous

Urs J Muehlematter, Hannes W Nagel, Anton Becker, Julian Mueller, Kerstin N Vokinger, Felipe de Galiza Barbosa, Edwin E G T Ter Voert, Patrick Veit-Haibach, Irene A Burger

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. European journal of nuclear medicine and molecular imaging · 2022
    Pooled it
  2. PET/MRI in prostate cancer: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2021
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Impact of TOF on Brain PET With Short-LivedFrontiers in medicine · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Urs J MuehlematterDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland. urs.muehlematter@usz.ch.
Hannes W NagelDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Anton BeckerDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Julian MuellerDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Kerstin N VokingerUniversity Hospital Zurich, Zurich, Switzerland.
Felipe de Galiza BarbosaDepartment of Diagnostic Imaging, Sirio Libanes Hospital, Sao Paulo, Brazil.
Edwin E G T Ter VoertDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Patrick Veit-HaibachDepartment Joint Medical Imaging, Toronto General Hospital, Toronto, ON, Canada.
Irene A BurgerDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
University Hospital of Zurich · CHHospital Sírio-Libanês · BRToronto General Hospital · CAUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccurate attenuation correction (AC) is an inherent problem of positron emission tomography magnetic resonance imaging (PET/MRI) systems. Simulation studies showed that time-of-flight (TOF) detectors can reduce PET quantification errors in MRI-based AC. However, its impact on lesion detection in a clinical setting with

resultsNon-TOF SUV was significantly lower compared to TOF in all osseous structures, except the skull, in primary lesions of the prostate, and in pelvic nodal and osseous metastasis. Concerning lymph node metastases, both experienced readers detected 16/19 (84%) on TOF PET, whereas on non-TOF PET readers 1 and 2 detected 11 (58%), and 14 (73%), respectively. With TOF PET readers 1 and 2 detected 14/15 (93%) and 11/15 (73%) bone metastases, respectively, whereas detection rate with non-TOF PET was 73% (11/15) for reader 1 and 53% (8/15) for reader 2. The interreader agreement was good for osseous metastasis detection on TOF (kappa 0.636, 95% confidence interval [CI] 0.453-0.810) and moderate on non-TOF (kappa = 0.600, CI 0.438-0.780).

conclusionTOF reconstruction for

Indexed as

Attenuation correctionPET/MRIProstate cancerTime-of-flight

Identifiers

PMID29855728
PMCPMC5981153
OpenAlexW4214864497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.